Zobrazeno 1 - 7
of 7
pro vyhledávání: '"A61P43/00"'
The present disclosure relates to an oral composition for the controlled release of caffeine over time, products, method of obtaining and uses thereof. In view of the drawbacks to the prior art, the technical problem underlying the invention was to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___02017::446cdcc5a185b5c6b6f53294ee8e26c9
Autor:
Virginia Tech Intellectual Properties, Inc., Iowa State University Research Foundation, Inc., Halbur, Patrick G., Meng, Xiang-Jin, Fenaux, Martijn
The present invention relates to infectious DNA clones, infectious chimeric DNA clones of porcine circovirus (PCV), vaccines and means of protecting pigs against viral infection or postweaning multisystemic wasting syndrome (PMWS) caused by PCV2. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2485::8600468f73b7ad6db58ad6ff5937d6cf
https://hdl.handle.net/10919/102809
https://hdl.handle.net/10919/102809
Autor:
IPF PHARMACEUTICALS GMBH, FORSSMANN WOLF-GEORG, DREXLER HELMUT, WALDEN MICHAEL, SCHIEFFER BERNHARD, SCHMIDT BORIS
The invention concerns a compound having structural formula (I), wherein R represents H, substituted or unsubstituted alkyl or acyl groups, especially methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert. Butyl; X = halogen or OH; R represents H,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=epopatstat__::e21ec17a0f0cc2bec8ca16ab62b56c40
https://register.epo.org/application?number=EP0105043
https://register.epo.org/application?number=EP0105043
Malnourishment leading to a decrease in body weight interferes with estrogen secretion in women, causing deleterious effects on bone density and on the menstrual cycle. The invention is based on the discovery that it is possible to reverse these meta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=epopatstat__::bd4a9f1a199fa4b54e447242a7cf6bf8
https://register.epo.org/application?number=EP0204615
https://register.epo.org/application?number=EP0204615
Autor:
JANSSEN PHARMACEUTICA NV, MABIRE DOMINIQUE JEAN-PIERRE, GUILLEMONT JEROME EMILE GEORGE, VAN DUN JACOBUS ALPHONSUS JOSE, SOMERS MARIA VICTORINA FRANCIS, WOUTERS WALTER BOUDEWIJN LEOPO
The present invention provides compounds of formula (I), their use as PARP inhibitors as well as pharmaceutical compositions comprising said compounds of formula (I) wherein n, R, R, R, R, and X have defined meanings.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=epopatstat__::2566e1d9eb1743f816b485cd0dbf35df
https://register.epo.org/application?number=EP2004013164
https://register.epo.org/application?number=EP2004013164